Clinical Trial: A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553377) titled 'A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease' on April 21.

Brief Summary: This study seeks to develop and test a novel digital pill system (DPS) that measures real-time medication ingestion and pairs it with a cognitive behavioral therapy (CBT)-based intervention to provide personalized, data-driven adherence support, with the long-term goal of providing new and improved personalized support and increase medication adherence for people with AUD and ALD.

Study Start Date: Oct., 2027

Study Type: INTERVENTIONAL

Condition: Alcohol Use Disorder Alcohol Associ...